Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Differences in plasma fatty acid composition related to chronic pancreatitis: A pilot study

  • Kristyn Gumpper-Fedus
  • , Olivia Crowe
  • , Phil A. Hart
  • , Valentina Pita-Grisanti
  • , Ericka Velez-Bonet
  • , Martha A. Belury
  • , Mitchell L. Ramsey
  • , Rachel M. Cole
  • , Niharika Badi
  • , Stacey Culp
  • , Alice Hinton
  • , Luis F. Lara
  • , Somashekar G. Krishna
  • , Darwin L. Conwell
  • , Zobeida Cruz-Monserrate

Producción científica: Articlerevisión exhaustiva

1 Cita (Scopus)

Resumen

Objectives Chronic pancreatitis (CP) is an inflammatory disease affecting the absorption of fat-soluble nutrients. Signaling in pancreatic cells that lead to inflammation may be influenced by fatty acids (FAs) through diet and de novo lipogenesis. Here, we investigated the relationship between plasma FA composition in CP with heterogeneity of etiology and complications of CP. Materials and Methods Blood and clinical parameters were collected from subjects with CP (n = 47) and controls (n = 22). Plasma was analyzed for FA composition using gas chromatography and compared between controls and CP and within CP. Results Palmitic acid increased, and linoleic acid decreased in CP compared with controls. Correlations between age or body mass index and FAs are altered in CP compared with controls. Diabetes, pancreatic calcifications, and substance usage, but not exocrine pancreatic dysfunction, were associated with differences in oleic acid and linoleic acid relative abundance in CP. De novo lipogenesis index was increased in the plasma of subjects with CP compared with controls and in calcific CP compared with noncalcific CP. Conclusions Fatty acids that are markers of de novo lipogenesis and linoleic acid are dysregulated in CP depending on the etiology or complication. These results enhance our understanding of CP and highlight potential pathways targeting FAs for treating CP.

Idioma originalEnglish
Páginas (desde-hasta)E416-E423
PublicaciónPancreas
Volumen53
N.º5
DOI
EstadoPublished - may 1 2024

Nota bibliográfica

Publisher Copyright:
© Wolters Kluwer Health, Inc. All rights reserved.

Financiación

Research reported in this publication was supported by startup funds from The Ohio State University Comprehensive Cancer Center (OSUCCC) (Z.C.-M.), ChiRhoClin Research Institute (Z.C.-M., D.L.C., P.A.H.), The National Pancreas Foundation (Z.C.-M.), the National Cancer Institute and National Institute of Diabetes and Digestive and Kidney Diseases U01DK108327

FinanciadoresNúmero del financiador
Ohio State University Comprehensive Cancer Center
ChiRhoClin Research Institute, Inc.
National Pancreas Foundation
National Childhood Cancer Registry – National Cancer Institute
National Institute of Diabetes and Digestive and Kidney DiseasesU01DK108327
National Institute of Diabetes and Digestive and Kidney Diseases

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Internal Medicine
    • Endocrinology, Diabetes and Metabolism
    • Hepatology
    • Endocrinology

    Huella

    Profundice en los temas de investigación de 'Differences in plasma fatty acid composition related to chronic pancreatitis: A pilot study'. En conjunto forman una huella única.

    Citar esto